Coronavirus January 22, 2022 Omicron undermining treatment for other health problems Roger Strukhoff was being treated for intestinal bleeding at a hospital outside Chicago this month when he suffered a mild heart attack.
Medications January 15, 2022 FDA approves first feline arthritis pain treatment The Food and Drug Administration (FDA) approved the first treatment for the control of pain associated with osteoarthritis in cats.
Arthritis January 13, 2022 Autoimmune Disease: A body at war with itself Autoimmune conditions result when the body attacks itself
PAIN MANAGEMENT January 11, 2022 At what temperature can you get frostbite? Signs, symptoms and everything else to know Commonly asked questions about frostbite, and what you can do to prevent it.
US September 23, 2021 REM sleep lower in migraine sufferers: study People who suffer from migraines may get less quality REM sleep, according to researchers.
Coronavirus August 16, 2021 Europe eyes arthritis drug for COVID-19 cases The European Medicines Agency has started an accelerated review process to determine if a common arthritis drug might help people hospitalized with severe COVID-19, months after the drug was granted an emergency use authorization in the U.S.
Coronavirus August 3, 2021 Lilly's COVID-19 drug reduces death risk in patients on ventilator Eli Lilly and Co. said new data from a Phase 3 trial showed its COVID-19 drug, baricitinib, was shown to reduce deaths in patients receiving mechanical ventilation.
Headaches and Migraines July 2, 2021 First migraine drug to both block, tackle headaches ‘shifts paradigm’ of treatment Most of Lilly Rockwell’s earliest memories from childhood are plagued with severe headaches to the point of vomiting. Her migraine disease worsened into adulthood as she worried over the impact on her career as a real estate agent, and quality time with family and friends.
Arthritis March 25, 2021 FDA panel rejects Pfizer’s arthritis drug as too risky U.S. health advisers sharply criticized an experimental arthritis drug Thursday, saying that it was too risky, even with limits on its use.
Medications March 24, 2021 FDA warns on unapproved CBD products marketed for pain relief The Food and Drug Administration issued a warning to two companies selling over-the-counter products labeled as containing cannabidiol (CBD) without receiving the agency’s approval to do so.
HEALTH February 4, 2021 FDA warns Pfizer's arthritis, colitis drug raises risk of heart issues and cancer The Food and Drug Administration (FDA) on Thursday warned that early results from a safety trial on Pfizer’s arthritis and colitis drug, tofacitinib, revealed an increased risk of heart issues and cancer when compared to another medicine.
